BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25695619)

  • 1. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.
    Chen Q; Sun W; Liao Y; Zeng H; Shan L; Yin F; Wang Z; Zhou Z; Hua Y; Cai Z
    Mol Med Rep; 2015 Jul; 12(1):219-25. PubMed ID: 25695619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
    Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
    Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
    Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway.
    Liu Z; Liu Z; Zhang Y; Li Y; Liu B; Zhang K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):211-217. PubMed ID: 28189676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ; Dong BK; Fan M; Jiang WX
    Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
    Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
    Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
    Feng ZM; Guo SM
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
    Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
    J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
    Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma.
    Chang H; Dong T; Ma X; Zhang T; Chen Z; Yang Z; Zhang Y
    Biochem Biophys Res Commun; 2015 Aug; 464(1):45-50. PubMed ID: 26032498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
    Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway.
    Chen MW; Wu XJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818811143. PubMed ID: 30482097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression.
    Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
    Life Sci; 2019 Oct; 234():116771. PubMed ID: 31421084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
    Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.